Moderna gets $25M for drugs to ward off bioweapons, infectious disease

Moderna Therapeutics, a fast-growing Cambridge biotech researching gene-based drugs, has a received a $25 million federal grant to develop easily-manufactured drugs for an array of infections and potential biological weapons...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.